The trajectory of Viagra presents a nuanced case for stakeholders in the medicinal sector. While initially a blockbuster success, creating huge profits, the patent lapse and the subsequent arrival of off-brand https://pharma562521.isblog.net/viagra-and-big-pharma-a-risky-bet-59124240